IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Molecular and Clinical Oncology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

1.26

h-Index

2022-2023

 16

Rank

2022-2023

 12650

SJR

2022-2023

 0.393

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Molecular and Clinical Oncology
Abbreviation Mol. Clin. Oncol.
Publication Type Journal
Subject Area, Categories, Scope Oncology (Q3); Cancer Research (Q4)
h-index 16
Overall Rank/Ranking 12650
SCImago Journal Rank (SJR) 0.393
Impact Score 1.26
Publisher Spandidos Publications UK
Country United Kingdom
ISSN 20499450, 20499469
Best Quartile Q3
Coverage History 2013, 2016-2022




About Molecular and Clinical Oncology


Molecular and Clinical Oncology is a journal covering the technologies/fields/categories related to Oncology (Q3); Cancer Research (Q4). It is published by Spandidos Publications UK. The overall rank of Molecular and Clinical Oncology is 12650. According to SCImago Journal Rank (SJR), this journal is ranked 0.393. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 16. The best quartile for this journal is Q3.

The ISSN of Molecular and Clinical Oncology journal is 20499450, 20499469. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular and Clinical Oncology is cited by a total of 891 articles during the last 3 years (Preceding 2022).


Molecular and Clinical Oncology Impact IF 2022-2023


The Impact IF 2022 of Molecular and Clinical Oncology is 1.26, which is computed in 2023 as per its definition. Molecular and Clinical Oncology IF is decreased by a factor of 0.54 and approximate percentage change is -30% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Molecular and Clinical Oncology Impact IF 2023 Prediction


Impact IF 2022 of Molecular and Clinical Oncology is 1.26. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Molecular and Clinical Oncology. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 1.26
2021 1.80
2020 1.61
2019 0.00
2018 0.00

Molecular and Clinical Oncology h-index


  Table Setting

Molecular and Clinical Oncology has an h-index of 16. It means 16 articles of this journal have more than 16 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Molecular and Clinical Oncology ISSN


The ISSN of Molecular and Clinical Oncology is 20499450, 20499469. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Molecular and Clinical Oncology Rank and SCImago Journal Rank (SJR)


The overall rank of Molecular and Clinical Oncology is 12650. According to SCImago Journal Rank (SJR), this journal is ranked 0.393. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Molecular and Clinical Oncology by Year


Year SJR
2023/2024 Coming Soon
2022 0.393
2021 0.393
2020 0.442
2019 0.213
2018

Ranking of Molecular and Clinical Oncology by Year


Year Ranking
2023/2024 Coming Soon
2022 12650
2021 12250
2020 11185
2019 17799
2018 33457

Molecular and Clinical Oncology Publisher


Table Setting

Molecular and Clinical Oncology is published by Spandidos Publications UK. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2013, 2016-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Molecular and Clinical Oncology is Mol. Clin. Oncol.. This abbreviation ('Mol. Clin. Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Molecular and Clinical Oncology


If your research field is/are related to Oncology (Q3); Cancer Research (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Molecular and Clinical Oncology?

Molecular and Clinical Oncology latest impact IF is 1.26. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 1.80 (2021) and 0.00 (2019), respectively, in the last 5 years. Moreover, its average IS is 0.93 in the previous 5 years.


What's the SCImago Journal Rank (SJR) of the Molecular and Clinical Oncology?

The Molecular and Clinical Oncology has an SJR (SCImago Journal Rank) of 0.393, according to the latest data. It is computed in the year 2023. In the past 5 years, this journal has recorded a range of SJR, with the highest being 0.442 in 2020 and the lowest being in 2018. Furthermore, the average SJR of the Molecular and Clinical Oncology over the previous 5-year period stands at 0.93.


What's the latest h-index of the Molecular and Clinical Oncology?

The latest h-index of the Molecular and Clinical Oncology is 16.


Who's the publisher of the Molecular and Clinical Oncology?

The Molecular and Clinical Oncology is published by the Spandidos Publications UK, with its country of publication being the United Kingdom.


What's the current ranking of the Molecular and Clinical Oncology?

The Molecular and Clinical Oncology is currently ranked 12650 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 5 years, this journal has experienced varying rankings, reaching its highest position of 11185 in 2020 and its lowest position of 33457 in 2018.


What's the abbreviation or short name for the Molecular and Clinical Oncology?

The standard ISO4 abbreviation for the Molecular and Clinical Oncology is Mol. Clin. Oncol..


Is the "Molecular and Clinical Oncology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Molecular and Clinical Oncology is classified as a journal that the Spandidos Publications UK publishes.


What's the scope or major areas of the Molecular and Clinical Oncology?

The Molecular and Clinical Oncology encompasses the following areas:

  • Oncology
  • Cancer Research

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Molecular and Clinical Oncology?

The Molecular and Clinical Oncology is assigned the following International Standard Serial Numbers (ISSN): 20499450, 20499469.


What's the best quartile of the Molecular and Clinical Oncology?

The best quartile for the Molecular and Clinical Oncology is Q3 (2022).


What's the coverage history of the Molecular and Clinical Oncology?

The Molecular and Clinical Oncology coverage history can be summarized as follows: 2013, 2016-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Zeitschrift fur Germanistische Linguistik journal 22945 De Gruyter Mouton 15 0.19
Historia journal 27560 Universidade Estadual Paulista 7 0.02
Journal of Field Archaeology journal 5639 Maney Publishing 43 2.38
Proceedings of the ASME Turbo Expo conference and proceedings 17577 54 0.00
Analysis in Theory and Applications journal 19346 Springer Netherlands 11 0.00
Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division conference and proceedings 17477 16 0.00
Applied Ecology and Environmental Research journal 17545 Corvinus University of Budapest 38 0.74
Revue Francophone des Laboratoires (discontinued) journal 23244 Elsevier Masson s.r.l. 8 0.00
Criminal Justice Review journal 8738 SAGE Publications Inc. 41 1.30
Palaeontographica Abteilung B: Palaeophytologie book series 15138 E. Schweizerbart'sche Verlagsbuchhandlung 16 2.20

Check complete list




Year wise Impact Score (IS) of Molecular and Clinical Oncology

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.26
2021 1.80
2020 1.61
2019 0.00
2018 0.00



Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All